ToP-DNJ
ToP-DNJ is a selective endoplasmic reticulum α-glucosidase II (GluII) inhibitor with an IC50 value of 9.0 μM. ToP-DNJ selectively inhibits the two catalytic reactions of GluII, and exhibits stronger activity in the first step of converting di-glycosylated glycans to mono-glycosylated glycans. ToP-DNJ exhibits anti-DENV activity. ToP-DNJ can be used in studies related to dengue virus infection.
For research use only. We do not sell to patients.
- CAS No.: 1508303-85-2
- Formula: C40H71NO6
- Molecular Weight:661.99
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
GluII 9.0 |
In Vitro
ToP-DNJ is a selective inhibitor of isolated endoplasmic reticulum α-glucosidase II, with an IC50 of 9.0 μM, and does not inhibit other tested α- or β-glucosidases at concentrations up to 50 μM[1].
ToP-DNJ inhibits both catalytic reactions of isolated endoplasmic reticulum α-glucosidase II, with higher inhibitory potency against the first reaction (IC50 = 14 μM) than against the second one (IC50 = 56 μM)[1].
ToP-DNJ exhibits anti-dengue virus activity in primary human monocyte-derived macrophages with an IC50 of 12.7 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1508303-85-2
-
Molecular Weight 661.99
-
Formula C40H71NO6
-
SMILES
O[C@@H]1[C@@H](CO)N(CCCCCOC2=C(C)C(C)=C3C(CC[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)O3)=C2C)C[C@H](O)[C@H]1O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)